8-K filings disclosing exchange listing deficiencies and delisting notices (Item 3.01), the earliest public delisting-risk signal.
Arrive AI Inc. received notification from Nasdaq on July 21, 2026 of non-compliance with minimum Market Value of Publicly Held Shares requirement ($15M). Company has 180 days until January 19, 2027 to regain compliance or face delisting.
Chegg notified by NYSE on July 24, 2026 of non-compliance with minimum share price requirement (average closing price below $1.00 over 30 trading days). Company has six-month cure period; stock remains listed during cure period. Failure to
Dyadic International regained compliance with Nasdaq Listing Rules 5550(a)(2) and 5550(b); common stock continues trading on Nasdaq Capital Market.
Nasdaq Staff determined to delist Company's securities from Nasdaq Capital Market due to failure to maintain minimum bid price of $1.00 per share. Company plans to appeal by July 29, 2026.
Company amended forbearance agreements with subordinated creditors regarding defaults from NYSE delisting, with waiver effective until August 22, 2026.
Fusemachines received notification from Nasdaq on July 24, 2026, that it does not maintain the required minimum Market Value of Publicly Held Shares of $15,000,000. Company has 180 calendar days until January 20, 2027, to regain compliance.
GoPro received notice from Nasdaq of non-compliance with minimum bid price rule. Stock price below $1.00 for 30 consecutive business days. Company has 180 days to regain compliance.
Invivyd received Nasdaq deficiency notice on July 23, 2026 for failure to maintain $1.00 minimum bid price for 30 consecutive business days. Company has until January 19, 2027 to regain compliance or faces potential delisting.
Nasdaq issued deficiency notice for failure to maintain $1.00 minimum bid price. Company has 180 days until January 19, 2027 to regain compliance. Continued listing not immediately affected.
Nasdaq notified Liminatus Pharma on July 20, 2026 that it has failed to regain compliance with the minimum bid price rule ($1/share) and is ineligible for a second 180-day extension. Company must submit written response by July 27, 2026; Pa
Nasdaq notified Odyssey Marine Exploration that it failed to maintain the $1.00 minimum bid price for 30 consecutive business days. Company has until January 19, 2027 to regain compliance or face potential delisting.
Nasdaq notified company on July 20, 2026 that common stock failed to maintain $1.00 minimum bid price for 30 consecutive business days. Company has 180 days until January 19, 2027 to regain compliance or risks delisting.
Peraso received notice from Nasdaq on July 21, 2026 that it failed to maintain the $1 minimum bid price requirement. Company has 180 days (until January 19, 2027) to regain compliance or face delisting.
Nasdaq notified company on July 23, 2026 that Class A common stock closing bid price fell below $1.00 for 30 consecutive business days, failing minimum bid price requirement. Company has until January 19, 2027 to regain compliance.
Standard BioTools (NASDAQ: LAB) received notice of non-compliance with Nasdaq minimum bid price requirement ($1.00). Company has 180 days until January 19, 2027 to regain compliance or face delisting.
NYSE notice of non-compliance with Section 802.01C due to closing price below $1.00 over 30 trading days. Company has six months to regain compliance or faces delisting.
VivoSim Labs received notice from Nasdaq on July 20, 2026, that it failed to maintain minimum $2.5M stockholders' equity requirement. Company has 45 days to submit compliance plan. As of filing date, equity exceeds $2.5M due to warrant exer
Nasdaq granted company additional 180-day compliance period (until January 19, 2027) to cure minimum bid price deficiency of $1.00 per share. Delisting risk remains if compliance not achieved.
Fly-E Group received Nasdaq delinquency notice for failure to timely file Form 10-K for period ended March 31, 2026. Company filed Form 10-K on July 21, 2026, addressing non-compliance with Nasdaq Listing Rule 5250(c)(1).
InspireMD received notice on July 17, 2026 that it failed to maintain Nasdaq's minimum bid price of $1.00 per share. Company has until January 13, 2027 to regain compliance or faces delisting.